Veterinary medicines European public assessment report (EPAR): Vectormune FP ILT + AE, fowlpox, avian infectious laryngotracheitis vaccine (live, recombinant) and avian encephalomyelitis vaccine (live), Status: Authorised

Human medicines European public assessment report (EPAR): Kineret, anakinra, Date of authorisation: 08/03/2002, Revision: 37, Status: Authorised

Human medicines European public assessment report (EPAR): Simponi, golimumab, Date of authorisation: 01/10/2009, Revision: 52, Status: Authorised

Human medicines European public assessment report (EPAR): Zutectra, human hepatitis B immunoglobulin, Date of authorisation: 30/11/2009, Revision: 18, Status: Authorised

Guide for rapporteurs and coordinators on the multinational assessment teams

Human medicines European public assessment report (EPAR): Nplate, romiplostim, Date of authorisation: 04/02/2009, Revision: 30, Status: Authorised

Veterinary medicines European public assessment report (EPAR): Zulvac BTV, bluetongue virus vaccine (inactivated) (multistrain: 1 strain out of a set of 3), Status: Authorised

Frequently asked questions about parallel distribution

Human medicines European public assessment report (EPAR): Ondexxya, andexanet alfa, Date of authorisation: 26/04/2019, Revision: 19, Status: Authorised

Human medicines European public assessment report (EPAR): Mayzent, siponimod, Date of authorisation: 13/01/2020, Revision: 19, Status: Authorised